Ticker
IOVACompany Name
IOVANCE BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 422.5M | $ 129.16M | $ 293.35M |
3/31/2025 | $ 512.65M | $ 122.69M | $ 389.96M |
12/31/2024 | $ 457.02M | $ 122.34M | $ 334.68M |
9/30/2024 | $ 498.58M | $ 118.06M | $ 380.52M |
6/30/2024 | $ 482.26M | $ 93.64M | $ 388.62M |
3/31/2024 | $ 385.53M | $ 83.21M | $ 302.32M |
12/31/2023 | $ 307.85M | $ 110.31M | $ 197.54M |
9/30/2023 | $ 382.59M | $ 90.95M | $ 291.63M |
6/30/2023 | $ 274.88M | $ 88.64M | $ 186.24M |
3/31/2023 | $ 637.78M | $ 87.27M | $ 550.51M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for IOVANCE BIOTHERAPEUTICS INC is calculated as follows: AssetsC [ $ 723.59M ] - LiabilitesC [ $ 64.39M ]
(=) Working Capital [ $ 659.2M ]
Minimum
Jun 30, 2023
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 2.79K |
---|---|
min | $ -465.2M |
max | $ 607.04M |
average | $ 96.23M |
median | $ 32.11M |
std | $ 173.96M |